2
Registered trials
0
Recruiting
2
Unique sponsors
1
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
L
Oncology (ATC L)
1
Mechanism of action (INN-stem analysis)
Receptor fusion protein
1 substance
Phase III:
1
Phase I (Other):
1
Phase III
1 trial-
EndedAlvotech Swiss AG CommercialAFLIBERCEPT
Phase I (Other)
1 trial-
EndedBreye Therapeutics ApS CommercialIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Breye Therapeutics ApS | Commercial | 1 | Phase I (Other) | 0 |
| Alvotech Swiss AG | Commercial | 1 | Phase III | 0 |
New trials by year
2024
1
2025
1